PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 1 filers reported holding PEAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,813,679 | -42.2% | 10,859,050 | 0.0% | 23.91% | +7.0% |
| Q3 2022 | $22,152,000 | +32.5% | 10,859,050 | 0.0% | 22.34% | +20.3% |
| Q2 2022 | $16,723,000 | -69.5% | 10,859,050 | 0.0% | 18.57% | -58.3% |
| Q1 2022 | $54,838,000 | -18.5% | 10,859,050 | 0.0% | 44.55% | +14.9% |
| Q4 2021 | $67,326,000 | – | 10,859,050 | – | 38.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arboretum Ventures, LLC | 10,859,050 | $2,769,058 | 8.16% |
| Palantir Technologies Inc. | 700,000 | $178,500 | 1.14% |
| 5AM Venture Management, LLC | 16,744,113 | $4,269,749 | 1.09% |
| TB Alternative Assets Ltd. | 2,071,865 | $528,326 | 0.13% |
| EDBI Pte Ltd | 427,070 | $108,903 | 0.12% |
| Temasek Holdings (Private) Ltd | 26,803,573 | $6,834,911 | 0.04% |
| SoftBank Group | 12,100,078 | $3,085,520 | 0.04% |
| Sarissa Capital Management LP | 500,356 | $127,591 | 0.02% |
| Perceptive Advisors | 900,548 | $229,639 | 0.01% |
| Legal & General Group Plc | 7,198 | $1,836 | 0.00% |